Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

Mark G. Kris, Bruce E. Johnson, Lynne D. Berry, +25

JAMA

Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience

Lynette M. Sholl, Dara L. Aisner, Marileila Varella‐Garcia, +14

Journal of Thoracic Oncology

OncologySomatic VariantOncogenic AgentMedicineLung Adenocarcinoma +6

Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps

Bob Chen, Cherie’ R. Scurrah, Eliot T. McKinley, +49

Cell

Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience

Badi El Osta, Madhusmita Behera, Sungjin Kim, +12

Journal of Thoracic Oncology

MedicinePathologyCancer GenomicsCancer GeneticsOncology +3

Clinicopathologic Predictors of Sentinel Lymph Node Metastasis in Thin Melanoma

Dale Han, Jonathan S. Zager, Yu Shyr, +17

Journal of Clinical Oncology

Identification of driver mutations in tumor specimens from 1,000 patients with lung adenocarcinoma: The NCI’s Lung Cancer Mutation Consortium (LCMC).

Mark G. Kris, B. E. Johnson, D J Kwiatkowski, +17

Journal of Clinical Oncology

Surgical OncologyCancer PathologyCancer ManagementLung AdenocarcinomaImmunology +16

The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations—The Lung Cancer Mutation Consortium (LCMC2)

Dara L. Aisner, Lynette M. Sholl, Lynne D. Berry, +24

Clinical Cancer Research

<i>HER2</i> mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium

Rathi N. Pillai, Madhusmita Behera, Lynne D. Berry, +6

Cancer

MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium

Robin Guo, Lynne D. Berry, Dara L. Aisner, +8

Journal of Thoracic Oncology

OncologyMet AmplificationMedicinePathologyBronchial Neoplasm +7

Identifying the Appropriate FISH Criteria for Defining MET Copy Number–Driven Lung Adenocarcinoma through Oncogene Overlap Analysis

Sinéad Noonan, Lynne D. Berry, Xian Lu, +9

Journal of Thoracic Oncology

Oncogenic AgentMedicineAppropriate Fish CriteriaPathologyBronchial Neoplasm +7